Global Clinical Chemistry market report 2024, Forecast To 2033
26 Jan, 2024
The clinical chemistry market has witnessed strong growth, escalating from $14.04 billion in 2023 to $15.02 billion in 2024, demonstrating a solid compound annual growth rate (CAGR) of 7.0%. This expansion is attributed to increased demand for diagnostic testing, the overall growth of the healthcare industry, an aging population, heightened disease diagnosis and management, and significant research and development. Continuing on this trajectory, the market size is projected to reach $20.06 billion in 2028, with a CAGR of 7.5%. Factors contributing to this growth include increasing demand for precision medicine, the need for biomarker discovery, rising demand for personalized healthcare, emerging infectious diseases, and the adoption of telemedicine and remote monitoring. Notable trends encompass advanced analytical techniques, AI and machine learning integration, technological innovations, laboratory automation, and cutting-edge solutions.
Global Clinical Chemistry Market Key Driver
The clinical chemistry market is thriving due to the rising prevalence of chronic diseases globally. According to the World Health Organization in September 2023, chronic diseases cause 74% of all deaths, totaling 41 million people annually. This increase in chronic diseases is expected to propel the clinical chemistry market in 2023, with continued expansion in 2024 and 2028.
Get A Free Sample Of The Global Clinical Chemistry Market ReportGlobal Clinical Chemistry Market Segments
The global clinical chemistry market covered in this report is segmented –
1) By Product: Analyzers, Reagents And Consumables
2) By Application: General Chemistry Test, Liver Function Test, Kidney Function Test, Urinalysis, Electrolyte Panel, Lipid Profile, Specialty Chemical Test, Other Applications
3) By End User: Hospitals, Diagnostic Or Pathology Centers, Ambulatory Surgery Centers, Other End Users
By Geography: The regions covered in the Clinical Chemistry market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa.
Major Clinical Chemistry Industry Players
Abbott Laboratories, F. Hoffmann-La Roche Ltd., ELITechGroup SAS, Beckman Coulter Inc., Thermo Fisher Scientific Inc., Siemens AG, Ortho Clinical Diagnostics Holdings plc, Diatron Mi Apac Private Limited, Nova Biomedical Corporation, Johnson & Johnson Services Inc., Alfa Wassermann USA Inc., HORIBA Ltd., Mindray Medical International Limited, Randox Laboratories Limited, SYNLAB International GmbH, Agilent Technologies Inc., Alcami Corporation, ARUP Laboratories Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Eurofins Scientific SE, GE Healthcare Technologies Ltd., Horiba Medical Inc., Laboratory Corporation, Luminex Corporation, Medtronic plc, PerkinElmer Inc., Quest Diagnostics Incorporated, Sysmex Corporation, Tosoh Corporation, Trinity Biotech plc, Waters Corporation, Werfen S.A.
Get The Full Global Clinical Chemistry Market Report
Clinical Chemistry Market Overview
Clinical chemistry is a quantitative field of study that measures the concentrations of biologically significant chemicals, or analytes, in bodily fluids.
Clinical Chemistry Global Market Report 2023 provides data on the global clinical chemistry market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The clinical chemistry market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.